StockStory.org on MSN2d
Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...
11d
Zacks Investment Research on MSN4 GARP Stocks That Investors Can Scoop Up for Maximum ReturnsGrowth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits. The GARP approach helps identify stocks priced below the market or any suitable target determined by a ...
Cencora (NYSE:COR) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Wells Fargo raised the firm’s price target on Cencora (COR) to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is updating its model following Cencora’s results and ...
As the crypto with the ninth-highest market cap, DOGE is far from in the doghouse, but it's still a risky play.
COR opened at $253.88 on Wednesday. The firm has a market cap of $49.23 billion, a P/E ratio of 36.11, a P/E/G ratio of 1.31 and a beta of 0.51. Cencora has a 12 month low of $214.77 and a 12 ...
Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 and ...
Cencora has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.
Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.2% over the past month. The stock hit a new 52-week high of $262.56 in the previous session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results